Galapagos NV (AMS:GLPG)
Netherlands · Delayed Price · Currency is EUR 28.74
-0.82 (-2.77%)
Oct 14, 2025, 5:35 PM CET
Galapagos NV Employees
Galapagos NV had 704 employees as of December 31, 2024. The number of employees decreased by 419 or -37.31% compared to the previous year.
Employees
704
Change (1Y)
-419
Growth (1Y)
-37.31%
Revenue / Employee
€493,923
Profits / Employee
€509,452
Market Cap
1.89B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Dec 31, 2021 | 1,309 | -180 | -12.09% |
| Dec 31, 2020 | 1,489 | 486 | 48.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Galapagos NV News
- 13 days ago - Galapagos Receives Non-Binding Offers For Cell Therapy Business - Nasdaq
- 13 days ago - Galapagos (GLPG) Explores Strategic Alternatives for Cell Therapy Division - GuruFocus
- 13 days ago - Galapagos (GLPG) Considers Strategic Options for Cell Therapy Unit - GuruFocus
- 13 days ago - Galapagos updates on strategic alternatives for cell therapy business - Seeking Alpha
- 13 days ago - Biotechnology firm Galapagos receives offers for cell-therapy business - Reuters
- 13 days ago - Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business - GlobeNewsWire
- 2 months ago - Galapagos Creates New Subscription Right Plan - GlobeNewsWire
- 2 months ago - Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma - GlobeNewsWire